1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Dyspepsia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Dyspepsia Clinical Trials by Region
2.2.2 Average Enrollment of Dyspepsia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Dyspepsia Treatment, 2019

3. Region wise Dyspepsia Clinical Trials
3.1 Asia Pacific Dyspepsia Clinical Trials by Country
3.2 Europe Dyspepsia Clinical Trials by Country
3.3 North America Dyspepsia Clinical Trials by Country
3.4 Middle East and Africa Dyspepsia Clinical Trials by Country
3.5 South and Central America Dyspepsia Clinical Trials by Country

4. Dyspepsia Clinical Trial Trends
4.1 Start Year wise Dyspepsia Clinical Trials
4.2 Phase wise Dyspepsia Clinical Trials
4.3 Trial Status wise Dyspepsia Clinical Trials
4.4 Trial Type wise Dyspepsia Clinical Trials

5. Dyspepsia Average Enrollment Trends
5.1 Average Enrollment in Dyspepsia Trials by Year
5.2 Average Enrollment in Dyspepsia Trials by Phase
5.3 Average Enrollment in Dyspepsia Trials by Status
5.4 Average Enrollment in Dyspepsia Trials by Type of Trial

6. Companies Participating in Dyspepsia Clinical Trials
6.1 Dyspepsia Trials by Sponsor Type
6.2 Dyspepsia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Dyspepsia Trials- Phase 1
7.2 Dyspepsia Trials- Phase 2
7.3 Dyspepsia Trials- Phase 3
7.4 Dyspepsia Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Dyspepsia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Dyspepsia Clinical Trials and Enrolment
Figure 5: Europe - Country wise Dyspepsia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Dyspepsia Clinical Trials and Enrolment
Figure 7: North America - Country wise Dyspepsia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Dyspepsia Clinical Trials and Enrolment
Figure 9: Dyspepsia Clinical Trials by Phase
Figure 10: Dyspepsia Clinical Trials by Trial Status
Figure 11: Dyspepsia Clinical Trials by Type
Figure 12: Dyspepsia Clinical Trials by Sponsor Type
Figure 13: Dyspepsia Clinical Trials by Leading Sponsors
Figure 14: Dyspepsia Average Enrollment by Phase
Figure 15: Dyspepsia Average Enrollment by Trial Status
Figure 16: Dyspepsia Average Enrollment by Type
Figure 17: Dyspepsia- Average Enrolment by Type of Sponsors
Figure 18: Dyspepsia- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Dyspepsia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Dyspepsia Clinical Trials and Enrolment
Table 5: Europe - Country wise Dyspepsia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Dyspepsia Clinical Trials and Enrolment
Table 7: North America - Country wise Dyspepsia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Dyspepsia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Dyspepsia Average Enrollment by Phase
Table 15: Dyspepsia Average Enrollment by Trial Status
Table 16: Dyspepsia Average Enrollment by Type
Table 17: Dyspepsia- Average Enrolment by Type of Sponsors
Table 18: Dyspepsia- Enrolment by Leading Sponsors

Companies mentioned
Allergan Plc, Astellas Pharma Inc, AstraZeneca Plc, Cadila Healthcare Ltd, Dr. Reddy's Laboratories Ltd, Eisai Co Ltd, Lupin Ltd, Novartis AG, Tsumura & co, Zeria Pharmaceutical Co Ltd